Agios Pharmaceuticals Inc. buy Bank of America Co.
Start price
20.11.25
/
50%
€20.00
Target price
20.11.26
€27.77
Performance (%)
26.00%
Price
29.05.26
€25.20
Summary
This prediction is currently active. The prediction currently has a performance of 26.00%. This prediction currently runs until 20.11.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 3.279% | 3.279% |
| iShares Core DAX® | 1.051% | 4.896% |
| iShares Nasdaq 100 | 2.414% | 11.649% |
| iShares Nikkei 225® | 4.165% | 13.991% |
| iShares S&P 500 | 0.963% | 6.365% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target lowered by analysts at Bank of America Corporation from $54.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.20
29.05.26
29.05.26
€34.37
29.05.27
29.05.27
0.00%
29.05.26
29.05.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.80
21.04.26
21.04.26
€34.81
21.04.27
21.04.27
10.53%
29.05.26
29.05.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€28.80
24.12.26
24.12.26
5.88%
29.05.26
29.05.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.80
22.07.25
22.07.25
€43.63
22.07.26
22.07.26
-23.67%
29.05.26
29.05.26